Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Southern Medical Journal|March 1, 1992
Cost of screening for colorectal cancer: results of a community mass screening program and review of the literatureE G Trehu, J N CooperJournal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Possible myocardial toxicity associated with interleukin-4 therapyE G Trehu, J M Isner, J W Mier, et al.Cytokine|November 1, 1992
Suppression of IL-2-induced SAA gene expression in mice by the administration of an IL-1 receptor antagonistR P Numerof, J D Sipe, E G Trehu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
A two-part phase I trial of high-dose interleukin 2 in combination with soluble (Chinese hamster ovary) interleukin 1 receptorD F McDermott, E G Trehu, J W Mier, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinomaJ S Du Bois, E G Trehu, J W Mier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1996
Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimeraE G Trehu, J W Mier, J S Dubois, et al.Pageof 1